StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.47−0.01 (-0.68%)

Close on Nov 18, 2026Market cap $1.31MP/E –Yield –

PMGC operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$2.20M–
Q3 FY2024Sep 30, 2024-$625.62K–
Q2 FY2024Jun 30, 2024-$1.41M–
Q1 FY2024Mar 31, 2024-$1.68M–
Q3 FY2023Sep 30, 2023-$785.55K–
Q2 FY2023Jun 30, 2023-$1.05M–
Q1 FY2023Mar 31, 2023-$846.39K–

More PMGC figures

See a number that looks wrong?